Machine Learning

With its lead drug in Phase 3 and a strong Biogen partnership, Stoke Therapeutics prepares to update investors on its disease-modifying Dravet syndrome therapy.

ADP's latest dividend declaration highlights its financial strength and commitment to shareholders, cementing its status as a reliable income-generating stock.

A new study reveals why GLP-1 drugs work for some and not others. 23andMe's research could personalize obesity treatment for millions of patients.

A single-dose therapy wiped out aggressive glioblastoma tumors in a landmark pre-clinical study, paving the way for human trials in 2026.

As AI and automation reshape global tax, a new online certificate from IBFD and VU Amsterdam aims to equip professionals with crucial, future-proof skills.

Sweed hires tech growth expert Brad Cross as CRO, signaling a major push to dominate the dispensary tech market with its all-in-one AI platform.

A major upgrade to RxERP's platform introduces unit-level audit logging, promising to redefine data integrity and drive efficiency beyond simple compliance.

A new app lets users bet on viral videos, raising over $1M to financialize social media. But does it create a new economy or a new set of risks?

The simulation software leader is betting big on its users, launching a high-stakes contest to showcase the future of engineering and boost careers.

Progressive Grocer’s annual awards name 68 top products, revealing key trends in sustainability, wellness, and global flavors shaping our grocery carts.

Galloway Capital Partners takes a 5.44% stake in Chegg, arguing the ed-tech firm is undervalued and a strategic split could revive its fortunes.

Jacksonville agency Dion Marketing lands a major account, leveraging AI and SEO to boost local visibility for 39 Monster Mini Golf franchise locations.

With stellar trial data for its cholesterol drug obicetrapib, NewAmsterdam Pharma faces investors as it navigates a competitive market and awaits key results.

As uranium prices soar, one explorer uses advanced 3D modeling and AI to unlock new discovery potential in Canada's richest uranium district.

As Spectral AI preps its revolutionary DeepView wound scanner for launch, new CFO David McGuire brings crucial public company expertise to a pivotal transition.

Ovid Therapeutics is spotlighting a novel drug class targeting KCC2, a key brain protein. Could this be the key to treating psychosis and epilepsy?

From commercial fleets to combat readiness, Xos targets the defense sector with its grid-independent mobile charging platform for military operations.

CorTec's brain-computer interface gets FDA Breakthrough status, offering new hope for restoring movement in millions of chronic stroke survivors.

Acclaro Medical's new AuraLux laser combines 'cold ablative' tech with a unique business partnership, aiming to make advanced skin treatments safe for all.

American Public Media's new Inform Media Network consolidates dozens of stations, offering advertisers a brand-safe path to a premium podcast audience.